- Home
- ASND vs TECH Comparison
ASND vs TECH Comparison
Compare ASND & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- TECH
- Stock Information
- Founded
- ASND 2006
- TECH 1976
- Country
- ASND Denmark
- TECH United States
- Employees
- ASND 1017
- TECH N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASND Health Care
- TECH Health Care
- Exchange
- ASND Nasdaq
- TECH Nasdaq
- Market Cap
- ASND 12.2B
- TECH 9.9B
- IPO Year
- ASND 2015
- TECH 1989
- Fundamental
- Price
- ASND $208.32
- TECH $61.03
- Analyst Decision
- ASND Strong Buy
- TECH Buy
- Analyst Count
- ASND 17
- TECH 13
- Target Price
- ASND $245.76
- TECH $70.58
- AVG Volume (30 Days)
- ASND 407.0K
- TECH 1.7M
- Earning Date
- ASND 11-04-2025
- TECH 11-05-2025
- Dividend Yield
- ASND N/A
- TECH 0.52%
- EPS Growth
- ASND N/A
- TECH N/A
- EPS
- ASND N/A
- TECH 0.46
- Revenue
- ASND $576,332,355.00
- TECH $1,219,635,000.00
- Revenue This Year
- ASND $104.98
- TECH $3.64
- Revenue Next Year
- ASND $79.91
- TECH $7.59
- P/E Ratio
- ASND N/A
- TECH $133.17
- Revenue Growth
- ASND 54.50
- TECH 5.23
- 52 Week Low
- ASND $118.03
- TECH $46.01
- 52 Week High
- ASND $216.45
- TECH $80.80
- Technical
- Relative Strength Index (RSI)
- ASND 57.09
- TECH 50.82
- Support Level
- ASND $195.03
- TECH $60.48
- Resistance Level
- ASND $208.39
- TECH $62.95
- Average True Range (ATR)
- ASND 8.24
- TECH 1.94
- MACD
- ASND -0.46
- TECH -0.54
- Stochastic Oscillator
- ASND 78.36
- TECH 19.32
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.